Log In
Print
BCIQ
Print
Print this Print this
 

MER5101

  Manage Alerts
Collapse Summary General Information
Company Mercia Pharma Inc.
DescriptionFragment of amyloid protein conjugated to an immunogenic carrier and formulated with MAS-1 adjuvant
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today